Thiotepa (TEPA)
N,N'N'-triethylenethiophosphoramide;
ThioTEPA is an organophosphorus compound with the formula SP(NC2H4)3. It is an analogue of N,N',N''- triethylenephosphoramide (TEPA). This molecule features tetrahedral phosphorus and is structurally akin to phosphate. It is derived from aziridine and thiophosphoryl chloride. Thiotepa has been previously used in the palliation of a wide variety of neoplastic diseases. The more consistent results have been seen in: adenocarcinoma of the breast, adenocarcinoma of the ovary, superficial papillary carcinoma of the urinary bladder and for controlling intracavitary effusions secondary to diffuse or localized neoplastic diseases of various serosal cavities. Thiotepa is also used as intravesical chemotherapy in bladder cancer. Thiotepa main toxicity is myelosuppression. The most serious complication of excessive therapy is bone marrow depression, causing leukopenia, thrombocytopenia, and anemia.
Organism species: Pan-species (General)
- Customized Service n/a Complete Antigen of Thiotepa (TEPA) Antigenic Transformation Customized Service Offer
- Customized Service n/a Monoclonal Antibody to Thiotepa (TEPA) Monoclonal Antibody Customized Service Offer
- Customized Service n/a Polyclonal Antibody to Thiotepa (TEPA) Polyclonal Antibody Customized Service Offer
- Customized Service n/a CLIA Kit for Thiotepa (TEPA) CLIA Kit Customized Service Offer
- Customized Service n/a ELISA Kit for Thiotepa (TEPA) ELISA Kit Customized Service Offer
